The present study aimed to investigate the association between CD3+ and CD8+ T immune cells in the tumor microenvironment and clinicopathologic characteristics and blood indexes, including tumor markers, inflammatory indictors and lipid metabolism factors, for patients with CRC. Here, CD8A is linked to colorectal carcinoma.